Travoprost Implant for Open-Angle Glaucoma
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 110 (estimated)
- Sponsor
- Glaukos Corporation · Industry
This trial is looking for people with open-angle glaucoma or ocular hypertension to evaluate a new implant treatment. Participants will receive the Travoprost implant in the study eye.
You may be able to join if
- I have been diagnosed with open-angle glaucoma
- I have been diagnosed with ocular hypertension
You may not be able to join if
- I have had prior incisional glaucoma surgery in the study eye
- I have had prior argon laser trabeculoplasty in the study eye
- I have had prior minimally invasive glaucoma surgery in the study eye
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityEvaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Loading trial locations…